AAMRI submission to the Draft Treasury Law Amendment (Research and Development Incentive) Bill 2018

AAMRI submission to the Draft Treasury Law Amendment (Research and Development Incentive) Bill 2018

Following multiple reviews of the R&D tax incentive the Government announced major changes to how the program will work in the future. Importantly for the medical research sector, as part of these changes the Government announced that clinical trials would be exempt from the new $4m expenditure cap. The Treasury released draft legislation for public comment on how the new legislation will work, including the clinical trial exemption. AAMRI’s submission comments on the clinical trial exemption and makes suggestions on how the definition of a clinical trial could be further improved to ensure it covers the full range of clinical trial activities.